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ABSTRACT
Objectives: To assess the causes of bacteraemia in
young infants and susceptibility to ﬁrst-line antibiotics
(benzylpenicillin plus gentamicin) at the Queen
Elizabeth Central Hospital (QECH), Malawi during
2002e2007.
Design: Retrospective analysis of demographic and
microbiological data using laboratory records.
Setting: QECH is Malawi’s largest hospital with 7000
neonates admitted annually, 9% for septicaemia.
Patients: All infants aged 60 days or less admitted to
QECH that had a blood culture taken over the 6-year
period.
Main outcome measures: 6754 blood cultures were
taken. 3323 organisms were isolated: one-third were
pathogens, two-thirds contaminants. Gram-positive
organisms (53%) were more common than gram-
negatives (47%). Four organisms made up half of all
pathogens: Staphylococcus aureus (15.3%), group B
streptococci (13.5%), non-typhoidal salmonellae
(12.6%) and Escherichia coli (10.5%). Apart from
non-typhoidal salmonellae and Streptococcus
pneumoniae, most organisms were more common in
the ﬁrst week of life than later. Overall, 28% of isolates
during 2002e2007 were resistant to ﬁrst-line
antibiotic, higher than observed during 1996e2001
(22%). Penicillin susceptibility ﬂuctuated while
gram-negative resistance to gentamicin increased
from 17% to 27% over the study period.
Conclusions: In the QECH, pathogens causing young
infant sepsis are an unusual mix of organisms seen in
both developed and developing countries. Resistance
to ﬁrst-line antibiotics is higher than observed in most
studies. Ongoing monitoring is needed and clinical
outcome data would aid interpretation of ﬁndings. A
high proportion of blood cultures were contaminated
with skin ﬂoradimproved training and supervision of
phlebotomists are needed to improve the utility of
taking blood cultures.
INTRODUCTION
The Queen Elizabeth Central Hospital
(QECH) in Blantyre, Malawi, is the country’s
largest hospital and a referral centre for the
southern region. Seven thousand neonates
are admitted annually, including w9% for
septicaemia. Septic infants aged 60 days or
less are treated with parenteral penicillin
(50000 units or 30 mg/kg three or four
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ARTICLE SUMMARY
Article focus
- Identiﬁcation of bacterial causes of sepsis in
young infants aged 2 months or less who
presented to the QECH, Malawi during
2002e2007.
- Documentation of antibiotic resistance patterns
of bacterial pathogens isolated during this
period.
- Changes in aetiology and antibiotic resistance
during this 6-year period compared with an
earlier audit (1996e2001).
Key messages
- We found an unusual range of organisms
infecting young infants, a range that lay
between those classically observed in developed
countries and those commonly reported in
developing countries illustrating the complexities
of local microbial ecology.
- We documented a concerning level of resistance
to empirical ﬁrst-line antibiotics: 28% of isolates
were resistant during 2002e2007 compared with
22% during 1996e2001.
- The high number of horizontally acquired
pathogens and the high proportion of contami-
nant organisms cultured highlight the need for
greater attention to infection control practices.
Strengths and limitations of this study
- One of the largest single-site studies of young infant
sepsis reviewing every blood culture sample taken
for sepsis during a 6-year period (2002e2007).
- Comparison with an earlier audit mapping trends
in organisms and antibiotic resistance over
a 12-year period.
- Clinical outcome data were not linked to
laboratory registers so the implications of the
high level of antibiotic resistance are not
immediately clear.
- The high number of contaminants isolated
may have obscured the growth of fastidious
organisms.
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Open Access Researchtimes daily) and gentamicin (6 mg/kg/day) as per
hospital policy. Earlier studies (1996e2001) at the
QECH had shown some resistance to this antibiotic
regimen.
1 2 We reviewed microbiological data from blood
cultures taken from children in this age group during
a 6-year period, 2002 to 2007, to assess further changes in
the causes of bacterial infections and antibiotic
resistance.
METHODS
We conducted a retrospective analysis of all blood
cultures from children aged 60 days or less admitted to
QECH during 2002e2007. We collected demographic
and microbiological data from ward admission and
laboratory registers and validated these against the
electronic microbiology database. Case notes were not
linked to these registers, so comorbid conditions (eg,
malnutrition, HIV status, low birth weight), length of
hospital stay and clinical outcomes could not be
assessed. Data on bacterial colonisation of mothers from
vaginal swabs and antibiotic treatment during delivery
were not available.
Prior to 2006, routine blood cultures were collected on
clinical suspicion of septicaemia after malaria had been
excluded. In order to save resources, from 2006, they
were taken only if ﬁrst-line antibiotic therapy had failed.
Samples were processed in the Malawi-Liverpool-Well-
come Trust Clinical Research Programme at QECH
using British Society for Antimicrobial Chemotherapy
guidelines to identify organisms and test for resistance to
antibiotics.
3 Isolates were classiﬁed as being either
resistant or susceptible to an antibiotic using the disc
diffusion methoddminimum inhibitory concentrations
were not routinely quantiﬁed.
Mixed skin ﬂora and four speciﬁc organisms were
considered contaminants and as such were excluded
from the analysis: Bacillus sp, Coagulase-negative staphylo-
coccus, diphtheroids and Micrococcus sp. Although Coagu-
lase-negative staphylococcus are recognised pathogens in
intensive care settings, particularly for premature and
low birth weight infants, we classiﬁed them as contami-
nants because care of sick infants at the QECH does not
involve central venous access or other invasive care
procedures.
EpiData 3.1 (EpiData Association) was used for data
entry. Data were analysed by isolates, age group, year and
resistance to antibiotics using Stata V.10.0 (StataCorp
LP). Missing data are reported to aid interpretation of
ﬁndings. In selected instances, we compared our data
with ﬁndings from an earlier audit of blood (and
cerebrospinal ﬂuid) cultures in the QECH.
2
Ethical approval was not required for a retrospective
audit of unlinked laboratory data.
RESULTS
Organisms isolated
Over the 6-year period, 6754 blood cultures were
performed on infants aged 60 days or less. Fifty-ﬁve per
cent (3726) were collected from inpatients of the main
paediatric nursery that were mostly born outside the
hospital; 40% (2673) were from infants in the special
care baby unit that were born at the QECH or in another
healthcare facility and transferred directly to this unit.
Two hundred and sixty-three specimens were from chil-
dren in other wards (3.9%) or the ward was not recorded
(1.4%). The number of blood cultures collected
increased annually until 2005, after which blood cultures
were taken only in children who did not clinically
improve on ﬁrst-line therapy.
Forty-four per cent (2971) of blood cultures grew
a single organism and 2.5% (168) grew two or more
organisms (table 1). One-third (31%) of organisms were
deﬁned as clinically important pathogens, while two-
thirds (69%) were contaminants. The proportion of
contaminants was similar in different age groups. The
proportion of blood cultures with contaminants,
Table 1 Summary of blood culture specimens and isolates, 2002e2007
Isolates
Number of
isolates per
specimen
Number of blood cultures Total number of isolates
2002 2003 2004 2005 2006 2007 Total Pathogens Contaminants All
None 0 409 576 676 1002 525 427 3615 ee e
Pathogens 1 150 186 153 205 97 71 862 862 e 862
2 e 2 1 51 83 2 4 08 0 e 80
3 ee3 eee39 e 9
Contaminants 1 270 458 379 540 274 188 2109 e 2109 2109
2 ee20 12 3 3 38 e 76 76
3 eeeeeeee e e
Mixed growth
(contaminant :
pathogen)
1:1 ee31 33 6 3 73 73 73 146
1:2 ee511e 71 4 7 2 1
2:1 ee15ee6 6 12 18
0:1* eee1 ee11 e 2
Total e 829 1222 1283 1817 909 694 6754 1045 2277 3323
*Two organisms were growndone was conﬁrmed as a pathogen; however, the details of the other organism were not recorded.
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earlier audit (table 2).
2
All pathogens were bacterial with the exception of
a single yeast isolate (Candida sp) cultured in 2005. A
greater proportion of gram-positive bacteria (53%; 551
isolates) were isolated than gram-negative bacteria (47%;
493 isolates). The change in policy in 2006 to collect
blood cultures only from children who failed empiric
ﬁrst-line treatment led to a number of changes: there
was a reduction in the proportion of pathogens
grownd11.4% of all cultures had at least one pathogen
in 2006e2007 compared with 15.7% in 2002e2005
(OR¼0.7, 95% CI 0.7 to 0.8, p¼0.000); and gram--
negative organisms became more common in
2006e2007 compared with 2002e2005 (OR¼1.6, 95%
CI 1.2 to 2.2, p¼0.003). The 10 most common organisms
isolated constituted 85% of all cultured pathogens (table
3). Four organisms made up over half of all pathogens
isolated: Staphylococcus aureus (15.3%), group B strepto-
cocci (GBS) (13.5%), non-typhoidal salmonellae species
(NTS) (12.6%) and Escherichia coli (10.5%). These four
organisms were the four most common isolates for 3 of
the 6 years under review and made up a signiﬁcant
proportion of isolates in each age group: 0e7 days
(47%), 8e28 days (66%) and 29e60 days (51%). With
the exception of NTS and Streptococcus pneumoniae, most
organisms were more common in the ﬁrst week of life
than later (ﬁgures 1 and 2).
Antibiotic susceptibility
More than 25% of tested isolates was resistant to both
penicillin and gentamicin in 2003, 2005, 2006 and 2007,
with 28% resistant for the combined 6-year period.
Organisms were more likely to be resistant to ﬁrst-line
therapy in 2007 than 2002 (OR¼2.2, 95% CI 1.1 to 4.3,
p¼0.024); however, there was no difference for the
period 2002e2005 when cultures were collected
routinely for septicaemia compared with 2006e2007
Table 2 Comparison of neonatal blood culture audits: 1996e2001 versus 2002e2007
Year of audit
Blood
cultures
Proportion* of blood cultures with Proportion of gram-
positive: gram-negative
pathogens No growth Contaminants Pathogen(s)
1996e2001 2442 50% (1213) 32% (781) 18% (448) 54%: 46%
2002e2005* 5151 50% (2663) 34% (1755) 16% (809) 55%: 45%
2006e2007* 1603 60% (952) 30% (478) 11% (183) 43%: 57%
2002e2007* 6754 54% (3615) 33% (2233) 15% (992) 53%: 47%
*Cumulative proportions may exceed 100% during 2002e2007 as some cultures grew both pathogens and contaminants.
Table 3 Ten most common pathogenic bacterial isolates for all age groups, 2002e2007 (includes isolates of those infants
whose age was unknown)
Bacterial isolates
Proportion of pathogens in each year
2002
(n[150)
2003
(n[190)
2004
(n[234)
2005
(n[281)
2006
(n[111)
2007
(n[78)
2002e2007
(n[1044)
Gram positive
Staphylococcus aureus 19% 19% 15% 16% 13% 4% 15.3%
Streptococcusdgroup B
(S agalactiae)
15% 13% 11% 18% 13% 6% 13.5%
Streptococcusdalpha
haemolytic
3% 2% 11% 12% 5% 5% 7.4%
Streptococcus pneumoniae 5% 4% 6% 5% 6% 15% 5.9%
Streptococcusdgroup D
(Enterococcus)
1% 2% 4% 10% 3% 4% 4.4%
Other gram positive 7% 5% 9% 4% 10% 0% 6.3%
Gram negative
Non-typhoidal Salmonellae sp* 23% 14% 9% 7% 16% 18% 12.6%
Escherichia coli 7% 13% 12% 7% 10% 19% 10.5%
Klebsiella sp* 6% 9% 4% 6% 10% 14% 7.3%
Enterobacter sp* 2% 5% 5% 5% 5% 4% 4.6%
Acinetobacter sp* 3% 2% 2% 5% 2% 5% 3.1%
Other gram negative 10% 12% 12% 6% 8% 5% 9.0%
Values in bold represent top three most common organisms in each year.
*Category is a combination of related organisms: Acinetobacter sp: A baumannii, A lwofﬁi and other Acinetobacter sp. Enterobacter sp:
E agglomerans, E cloacae, E sakazakii and other Enterobacter sp. Klebsiella sp: K pneumonia, K oxytoca and other Klebsiella sp. Non-typhoidal
Salmonellae sp: S typhimurium, S enteritidis and other Salmonella sp.
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had failed (OR¼1.0, 95% CI 0.7 to 1.5, p¼0.86). For
common organisms (NTS, E coli, Klebsiella sp, S aureus),
the proportion susceptible to ﬁrst-line antibiotics in
2006e2007 was similar to or greater than in 2002e2005.
Susceptibility to penicillin ﬂuctuated annually for all
isolates, while the resistance of gram-negative organisms
to gentamicindthe main antibiotic used to treat gram-
negative sepsisdincreased from 17% in 2002 to almost
27% in 2007 (OR¼1.8, 95% CI 0.8 to 4.2, p¼0.18)
(tables 4 and 5). A small number of both gram-negative
and gram-positive bacteria were resistant to ceftriaxone,
the second-line antibiotic therapy (including a single S
pneumoniae isolate that showed borderline intermediate
resistance to ceftriaxone (zone¼26 mm, sensitive¼27
mm, resistant¼22 mm)). Most gram-negative isolates
were susceptible to ciproﬂoxacin throughout the study
period (tables 4 and 5), whereas gram-negative resis-
tance to chloramphenicol, tetracycline and co-trimox-
azole remained consistently high for all common
organisms (table 5). The high proportion of gram-posi-
tive organisms resistant to penicillin (47% for
2002e2007) (table 4) reﬂects the frequency of S aureus
infections, of which 94% of isolates were penicillin
resistant. Of the staphylococci tested (32% of total), only
2% were resistant to cloxacillin.
DISCUSSION
Isolated organisms
In our study, a clinically important bacterial pathogen
was isolated from 15% (992) of young infant blood
specimens. The proportion of pathogens that were gram
positive (53%) and gram negative (47%) was similar to
the previous audit from 1996 to 2001 in the same
hospital.
2 Our observations among this cohort differ
from those reported elsewhere in Africa, which describe
a preponderance of gram-negative bacteria.
4 The range
of organisms found in our study ﬁts somewhere between
those classically observed in developed countriesdsuch
as GBS and S aureus
5dand those more commonly
reported from developing countries including Klebsiella,
Acinetobacter and Pseudomonas.
6 The four most common
Figure 1 Most frequent
pathogenic gram-positive isolates
by age group (n¼500; excludes 51
isolates where age was not
reported).
Figure 2 Most frequent
pathogenic gram-negative isolates
by age group (n¼427; excludes 66
isolates where age was not
reported). *Category is
a combination of related
organisms: Acinetobacter sp: A
baumannii, A lwofﬁi and other
Acinetobacter sp. Enterobacter
sp: E agglomerans, E cloacae, E
sakazakii and other Enterobacter
sp. Klebsiella sp: K pneumoniae,
K oxytoca and other Klebsiella sp.
NTS species (non-typhoidal
salmonellae): S typhimurium, S
enteritidis and other Salmonella
sp.
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ﬁndings from earlier studies in the French Antilles
7 and
South Africa,
8 particularly with regard to the frequency
of GBS, led some researchers to speculate about an
epidemiological transition occurring in middle-income
countries of bacteria infecting neonates or an inherent
bias in reporting with many neonates born at home
dying before reaching hospital.
6 Both suppositions seem
unlikely for the QECH: the United Nations ranks Malawi
in the lowest category for development, and the type of
organisms we isolated have remained unchanged since
1996,
2 while most (79%) mothers deliver in health
facilities in this part of Malawi.
9 The complex local
microbial ecology may partly explain the range of
organisms seen in the QECH.
Undernourished children (10% of paediatric inpa-
tients in the QECH) are more likely than well-nourished
children to have bacteraemia on admission and to be
infected with gram-negative organisms.
10 Gram-negative
sepsis due to NTS, is associated with the wet (malaria)
season in both The Gambia
11 and Malawi
12 and may
explain the predominance of NTS in our study
compared with reports from other developing countries
where Klebsiella spp and E coli are more common.
4 NTS
infection has also been shown to be common among
adults with HIV in Malawi with a high recurrence rate
after treatment.
13
Recent data from Zimbabwe found no difference in
GBS colonisation rates between women with and without
HIV-1 infection.
14 15 Studies within Malawi demonstrated
that GBS with type 3-polysaccharide antigen was
common and more virulent than other serotypes.
16 In
contrast, in the Gambia, maternal colonisation with GBS
type 3 is infrequent (6%) and neonatal GBS sepsis is
uncommon.
17
S pneumoniae was a leading cause of sepsis in older
infants aged 28e60 days, a ﬁnding consistent with other
local and international studies.
18
The pattern of pathogens reﬂects the fact that
neonates admitted to our wards are from both home and
health facility deliveries. The 2004 national demographic
and health survey showed that of all deliveries in the
southern region of Malawi, the catchment area for the
QECH, 79% were in health facilities.
9 We were not able
to track the place or time of birth in relation to the time
of hospital admission in our study. Therefore, we cannot
separate community-acquired infections from those
acquired in health facilities or maternally spread
organisms from those transmitted by unhygienic prac-
tices in health facilities or at home. Nonetheless, the
prevalence of gram-negative and S aureus infections in
young infants of all ages suggests that hospital-acquired
infections are important, and the high proportion of
contaminants isolated likely reﬂects a general lack of
infection control practices in the hospital and the need
for improved training.
The 2006 policy to take blood cultures only when ﬁrst-
line therapy failed led to relatively fewer pathogens
Table 4 Antibiotic susceptibility of gram-positive bacteria, 2002e2007 (n¼551)
Antibiotic
Proportion of isolates susceptible (number tested)
2002 2003 2004 2005 2006 2007 2002e2007
Penicillin 57% (74) 42% (85) 55% (106) 55% (149) 47% (51) 62% (26) 53% (491)
Erythromycin 86% (74) 81% (86) 69% (108) 67% (163) 81% (52) 78% (27) 75% (510)
Chloramphenicol 84% (74) 84% (86) 77% (109) 73% (167) 77% (53) 74% (27) 78% (516)
Co-trimoxazole 40% (75) 45% (84) 46% (105) 47% (165) 40% (53) 22% (27) 43% (509)
Gentamicin 55% (49) 100% (16) 77% (35) 73% (49) 93% (14) 100% (3) 73% (166)
Ceftriaxone 94% (18) 91% (74) 93% (69) 94% (109) 97% (36) 87% (23) 93% (329)
Tetracycline 40% (75) 47% (86) 31% (110) 35% (165) 38% (53) 52% (27) 38% (516)
First-line therapy
(penicillin and gentamicin)
88% (75) 60% (86) 78% (107) 74% (155) 71% (51) 73% (26) 74% (500)
Table 5 Antibiotic susceptibility of gram-negative bacteria, 2002e2007 (n¼493)
Antibiotic
Proportion of isolates susceptible (number tested)
2002 2003 2004 2005 2006 2007 2002e2007
Ampicillin 8% (73) 7% (100) 16% (100) 23% (96) 20% (56) 16% (49) 15% (474)
Chloramphenicol 35% (71) 28% (99) 40% (99) 39% (97) 51% (55) 41% (49) 38% (470)
Co-trimoxazole 19% (75) 17% (90) 31% (90) 37% (98) 27% (56) 22% (50) 26% (459)
Gentamicin 83% (75) 61% (100) 74% (100) 66% (102) 71% (56) 73% (51) 70% (484)
Ceftriaxone 100% (3) 75% (32) 91% (99) 88% (98) 95% (57) 86% (49) 88% (338)
Tetracycline 20% (70) 14% (91) 40% (5) 50% (2) 0% (2) e (0) 18% (170)
Ciproﬂoxacin 99% (70) 95% (102) 99% (101) 97% (102) 98% (54) 92% (51) 97% (480)
First-line therapy
(penicillin and gentamicin)*
83% (75) 61% (100) 74% (100) 66% (102) 71% (56) 73% (51) 70% (484)
*Reﬂects susceptibility to gentamicin only.
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children whose symptoms were due to fastidious organ-
isms and non-bacterial causes as well as those whose
clinical improvement lagged behind their microbiolog-
ical improvement (ie, they still had symptoms but no
bacteraemia). The policy change also led to more gram-
negative isolates that may reﬂect a reduced susceptibility
of these organisms to ﬁrst-line antibiotics as was seen in
2007 compared with 2002.
Antibiotic resistance and implications for empirical ﬁrst-line
antibiotic regimens
In this study, almost three in 10 isolates were resistant to
ﬁrst-line antimicrobial therapy. This is slightly higher
than was recorded in the previous audit and higher than
has been observed in much of the literature.
2 It is also
important to note the worrying shift towards resistance
to ceftriaxone, which had not been present earlier and
has emerged with the increasing use of ceftriaxone as
second-line therapy. Streptococcal species resistance is
of particular concern as there is no locally available
third-line antibiotic therapy.
As in other developing countries, we found the
appearance of multidrug-resistant gram-negative organ-
isms in particular Klebsiellae.
4 Resistance of Ec o l ito
gentamicin rose from 7% during 1996e2001 to 20%
during 2002e2007. Unfortunately, we lacked clinical data
to compare in vitro and in vivo resistance for these path-
ogens, which differed in past assessments in the QECH.
2
During the 6-year period of our study, there was a 10%
increase in resistance to chloramphenicol for gram-
positive pathogens possibly reﬂecting the widespread use
of this agent for ﬁrst-line treatment of sepsis, especially
in malnourished children. Few isolates of S aureus were
resistant to cloxacillin, a pattern seen elsewhere in the
developing world,
10 and most remain susceptible to
gentamicin.
Although this is a large data set and the level of resis-
tance to ﬁrst-line treatment of isolated pathogens is high
and rightly warrants concern, the implications for anti-
biotic therapy are not straightforward. On the one hand,
28% of pathogens were resistant to ﬁrst-line antibiotics.
Some laboratory-based surveillance systems recommend
revising treatment when more than 5% of isolates have
in vitro resistance to a particular antibiotic.
19 On the
other hand, of all blood culture specimens taken just
one in 25 grew a resistant organism. Interestingly, there
was no difference in the level of resistance to ﬁrst-line
therapy before and after the 2006 change in policy for
the indication of taking blood cultures.
Limitations
The pathogens isolated may not reﬂect the causative
organisms for young infant sepsis in rural Malawi for
a number of reasons: deaths of newborns outside the
hospital were not captured,
20 the number of isolates with
unknown ages could have affected the distribution of
organisms across the age categories, the high number of
contaminants isolated may have obscured the detection
of more fastidious pathogens and isolates taken after the
change in policy for taking blood cultures may reﬂect
organisms that grow despite antibiotic exposure. The
policy change may also have affected sensitivity patterns
when compared with previous studies. Length of stay,
which has been associated with nosocomial spread of
pathogens with higher levels of antibiotic resistance, was
not recorded in our data set.
CONCLUSIONS
This study is one of the largest single-site studies of its
kind in developing countries and highlights the impor-
tance of local aetiological assessments of young infant
sepsis for review of empiric treatment. Arguably, such
assessments are becoming more important as standard
treatment recommendations from international bodies
are increasingly applied. Audits should ideally be corre-
lated with clinical outcomes and separate community-
acquired from hospital-acquired infections to determine
the most appropriate ﬁrst-line antibiotic regimens. This
would also facilitate consideration of other preventive
measures such as vaccination and screening. For example,
the high prevalence of GBS sepsis in Malawi (combined
with a high case death rate (33%)) warrants routine
screening of mothers with antibiotic prophylaxis and
maternal immunisation.
16 The high proportion of blood
cultures contaminated by skin ﬂora in both this and the
previous audit shows an urgent need for additional
training and supervision. Other studies of children have
recorded lower contaminant rates of 13%e23%.
21 22
Trained phlebotomists and a formal internal system of
monitoring and quality assurance should be considered.
23
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